Tag Archive for: Cybin
Cybin Receives Conditional Approval to Trade on NYSE American
BusinessAnd in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies.
Psychedelic Business Spotlight: July 9, 2021
Business, Stock ReportsThis week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Business, Research, TreatmentCybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."